Conatus Pharmaceuticals Inc. Termination Agreements
6 Contracts & Agreements
- Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Joyce Reyes (Filed With SEC on November 9, 2023)
- Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Alfred P. Spada (Filed With SEC on November 9, 2023)
- Notice of Termination and Letter Agreement, dated September 18, 2023 by and between the Company and Steven J. Mento (Filed With SEC on November 9, 2023)
- Termination of Stockholder Agreements, dated January 28, 2020, by and among Histogen Inc., Lordship Ventures Histogen Holdings LLC, Pineworld Capital Limited, Gail K. Naughton,... (Filed With SEC on February 7, 2020)
- Conversion, Termination and Release Agreement, dated August 10, 2016, by and among Histogen Inc., Jonathan Jackson, Lordship Ventures LLC and Lordship Ventures Histogen Holdings... (Filed With SEC on February 7, 2020)
- Settlement, Release and Termination Agreement, dated April 5, 2019, by and among Histogen Inc., PUR Biologics, LLC, Wylde, LLC, Christopher Wiggins and Ryan Fernan (Filed With SEC on February 7, 2020)
